CHDR and LUMC receive a €1.9 million grant to study the use of medicinal cannabi...
23 Dec 2020
Proof of pharmacology of Org 48775-0, a p38 MAP kinase inhibitor, in healthy vol...
17 Nov 2020
Interested to join our team? Browse the latest openings
Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success
Finding biomarkers to predict clinical success
Providing clients with customised data management solutions for clinical trials
Pre-screened patients on standby for early-stage clinical trials
